The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Severe Hypoglycemia and Risks of Vascular Events and Death
Open accessAbstract
BACKGROUND: Severe hypoglycemia may increase the risk of a poor outcome in patients with type 2 diabetes assigned to an intensive glucose-lowering intervention. We analyzed data from a large study of intensive glucose lowering to explore the relationship between severe hypoglycemia and adverse clinical outcomes. METHODS: We examined the associations between severe hypoglycemia and the risks of macrovascular or microvascular events and death among 11,140 patients with type 2 diabetes, using Cox proportional-hazards models with adjustment for covariates measured at baseline and after randomization. RESULTS: During a median follow-up period of 5 years, 231 patients (2.1%) had at least one severe hypoglycemic episode; 150 had been assigned to intensive glucose control (2.7% of the 5571 patients in that group), and 81 had been assigned to standard glucose control (1.5% of the 5569 patients in that group). The median times from the onset of severe hypoglycemia to the first major macrovascular event, the first major microvascular event, and death were 1.56 years (interquartile range, 0.84 to 2.41), 0.99 years (interquartile range, 0.40 to 2.17), and 1.05 years (interquartile range, 0.34 to 2.41), respectively. During follow-up, severe hypoglycemia was associated with a significant increase in the adjusted risks of major macrovascular events (hazard ratio, 2.88; 95% confidence interval [CI], 2.01 to 4.12), major microvascular events (hazard ratio, 1.81; 95% CI, 1.19 to 2.74), death from a cardiovascular cause (hazard ratio, 2.68; 95% CI, 1.72 to 4.19), and death from any cause (hazard ratio, 2.69; 95% CI, 1.97 to 3.67) (P<0.001 for all comparisons). Similar associations were apparent for a range of nonvascular outcomes, including respiratory, digestive, and skin conditions (P<0.01 for all comparisons). No relationship was found between repeated episodes of severe hypoglycemia and vascular outcomes or death. CONCLUSIONS: Severe hypoglycemia was strongly associated with increased risks of a range of adverse clinical outcomes. It is possible that severe hypoglycemia contributes to adverse outcomes, but these analyses indicate that hypoglycemia is just as likely to be a marker of vulnerability to such events. (Funded by Servier and the National Health and Medical Research Council of Australia; ClinicalTrials.gov number, NCT00145925.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the frequency of severe hypoglycemia in these trials was 2 to 3 times higher in the intensive therapy groups”
From Targets for Glycemic Control (2018) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In people with type 2 diabetes and established, or very high risk for, cardiovascular disease (CVD), there is a clear association between an increased mortality and severe hypoglycemia (62,63) and symptomatic hypoglycemia (64).”
From Hypoglycemia (2018) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Post hoc analysis of clinical trials examining the effects of strict glycemic control on cardiovascular outcomes showed that exposure to severe hypoglycemia was strongly associated with a range of adverse outcomes, including death (2, 3).”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“In ADVANCE, where rates of hypoglycemia were low, a similar pattern was found (47).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
The cited source says what the claim attributes to it.
In the citing paper
“a higher mortality was reported in participants with 1 or more episodes of severe hypoglycemia in the ACCORD (30), ADVANCE (31) and VADT trials (25), irrespective of the different treatment arms in which individual participants were allocated.”
From Targets for Glycemic Control (2018) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial and in clinical practice (77,78).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [77]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“U500 regular insulin (contains 500 units/mL of regular insulin) may improve glycemia in the therapy of persons with DM who have severe insulin resistance (eg, require >200 total units of insulin/day).1102–1105”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1105]
Experimental — accuracy not yet measuredIn the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [197]
In the citing paper
“All three trials clearly demonstrated that an episode of severe hypoglycemia was associated with an increased risk of subsequent mortality.”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
In the citing paper
“In ADVANCE, where rates of hypoglycemia were low, a similar pattern was found (47).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial (90).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Rovere, M. T. L., Bigger, J. T., Marcus, F. I., Mortara, A., & Schwartz, P. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11144-8 · Cited by 3,120
Patel, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61303-8 · Cited by 2,054
Self-citationIntensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Self-citationGerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Flagged first, then by citations
Research works printed but not linked: 3
- Therneau TM, Grambsch PM. Modelling survival data: extending the Cox model. New York: Springer, 2000.
- Hoekstra JBL, 2009, Diabetologia, 52, 237
- Miller ME, 2009, Diabetologia, 52, 63
Cited by
Sorted by citations
Items 401–500 of 1,002
Fischer, L. E., Wolfe, B. M., Fino, N., Elman, M. R., Flum, D. R., Mitchell, J. E., Pomp, A., Pories, W. J., Purnell, J. Q., Patti, M.-E., et al. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.04.021 · Cited by 36
Miyamura, K., Nawa, N., Nishimura, H., Fushimi, K., & Fujiwara, T. (2022) · Environment International · doi:10.1016/j.envint.2022.107410 · Cited by 36
Davies, M. J., Lim, S. K., Slater, T., Goldney, J., Philis‐Tsimikas, A., Franco, D. R., Lamptey, R., Yates, T. E., Tankova, T. I., & Lingvay, I. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00687-w · Cited by 45
Wang, W., Chen, W., Liu, Y., Li, L., Li, S., Tan, J., & Sun, X. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066619889322 · Cited by 36
Fear of hypoglycaemia in patients with type 1 and 2 diabetes: a systematic review
Zhang, Y., Li, S., Zou, Y., Wu, X., Bi, Y., Zhang, L., Yuanyuan, Gong, W., & Hayter, M. (2020) · Journal of Clinical Nursing · doi:10.1111/jocn.15538 · Cited by 36
Fung, E., Lui, L.-T., Huang, L., Cheng, K. F., Lau, G. H. W., Chung, Y. T., Ahmadabadi, B. N., Xie, S., Lee, J. S. W., Hui, E., et al. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00251-8 · Cited by 36
Loh, H. H., Yee, A., Loh, H. S., Sukor, N., & Kamaruddin, N. A. (2015) · Primary care diabetes · doi:10.1016/j.pcd.2015.09.001 · Cited by 35
Fu, H., Xie, W., Curtis, B. H., & Schuster, D. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.922944 · Cited by 35
Sun, S., Hisland, L., Grenet, G., Gueyffier, F., Cornu, C., Jaafari, N., & Boussageon, R. (2021) · Therapies · doi:10.1016/j.therap.2021.10.002 · Cited by 39
Sciacqua, A., Succurro, E., Armentaro, G., Miceli, S., Pastori, D., Rengo, G., & Sesti, G. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10182-x · Cited by 35
Zhao, Y., Kachroo, S., Kawabata, H., Colilla, S., Mukherjee, J., Fonseca, V. A., Iloeje, U. H., & Shi, L. (2015) · Endocrine Practice · doi:10.4158/ep15640.or · Cited by 35
Hospitalization with hypoglycemia in patients without diabetes mellitus
Sako, A., Yasunaga, H., Matsui, H., Fushimi, K., Hamasaki, H., Katsuyama, H., Tsujimoto, T., Goto, A., & Yanai, H. (2017) · Medicine · doi:10.1097/md.0000000000007271 · Cited by 35
Fitchett, D., Inzucchi, S. E., Wanner, C., Mattheus, M., George, J. T., Vedin, O., Zinman, B., & Johansen, O. E. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz621 · Cited by 34
Key indices of glycaemic variability for application in diabetes clinical practice
Monnier, L., Bonnet, F., Colette, C., Renard, É., & Owens, D. R. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101488 · Cited by 35
Malmgren, S., & Åhrén, B. (2015) · Diabetologia · doi:10.1007/s00125-015-3518-7 · Cited by 34
Ogawa, S., Okawa, Y., Sawada, K., Goto, Y., Yamamoto, M., Koyama, Y., Baba, H., & Suzuki, T. (2015) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezv106 · Cited by 34
Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes
Laiteerapong, N., Cooper, J. M., Skandari, M. R., Clarke, P., Winn, A. N., Naylor, R. N., & Huang, E. S. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0537 · Cited by 36
Hsu, P., Sung, S., Cheng, H., Shin, S.-J., Lin, K., Chong, K., Yen, F., Yu, B.-H., Huang, C.-T., & Hsu, C.-C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00040 · Cited by 35
Spanakis, E. K., Umpierrez, G. E., Siddiqui, T., Zhan, M., Snitker, S., Fink, J. C., & Sorkin, J. D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02575 · Cited by 35
Toxicity of Metformin and Hypoglycemic Therapies
Akhter, M. S., & Uppal, P. (2020) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.08.004 · Cited by 36
Careful use to minimize adverse events of oral antidiabetic medications in the elderly
Scheen, A. J. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1912735 · Cited by 34
Heller, S. R., Geybels, M. S., Iqbal, A., Liu, L., Wagner, L., & Chow, E. (2021) · Diabetologia · doi:10.1007/s00125-021-05556-7 · Cited by 34
Self-citationTsujimoto, T., Yamamoto‐Honda, R., Kajio, H., Kishimoto, M., Noto, H., Hachiya, R., Kimura, A., Kakei, M., & Noda, M. (2014) · Medicine · doi:10.1097/md.0000000000000148 · Cited by 34
Brown, N. J. (2012) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2012.02.003 · Cited by 34
Mendelian Randomization and Estimation of Treatment Efficacy for Chronic Diseases
Schooling, C. M., Freeman, G., & Cowling, B. J. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws344 · Cited by 34
Oyagüez, I., Merino-Torres, J. F., Brito, M., Bellido, V., Cardona-Hernandez, R., Gomez-Peralta, F., & Morales-Perez, F. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001330 · Cited by 33
Lu, J., Wang, C., Cai, J., Shen, Y., Chen, L., Zhang, L., Lu, W., Zhu, W., Hu, G., Xia, T., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab532 · Cited by 33
Battelino, T., Lalic, N. M., Hussain, S., Ceriello, A., Majanović, S. K., Davies, S., Topsever, P., Heverly, J., Ulivi, F., Brady, K., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112111 · Cited by 34
Safety of antidiabetes medications: An update
Bailey, C. J. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.125 · Cited by 33
Diabetic nephropathy: new approaches for improving glycemic control and reducing risk
Schernthaner, G., & Schernthaner, G.-H. (2013) · Journal of Nephrology · doi:10.5301/jn.5000281 · Cited by 35
Rhee, C. M., Kovesdy, C. P., You, A. S., Sim, J. J., Soohoo, M., Streja, E., Molnar, M. Z., Amin, A., Abbott, K. C., Nguyen, D. V., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.04.022 · Cited by 33
Hypoglycemia and Elevated Troponin in Patients With Diabetes and Coronary Artery Disease
Rezende, P. C., Everett, B. M., Brooks, M. M., Vlachos, H., Orchard, T. J., Frye, R. L., Bhatt, D. L., & Hlatky, M. A. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.067 · Cited by 33
Tian, J., Ohkuma, T., Cooper, M. E., Harrap, S. B., Mancia, G., Poulter, N. R., Wang, J.-G., Zoungas, S., Woodward, M., & Chalmers, J. P. (2020) · Diabetes Care · doi:10.2337/dc19-1817 · Cited by 34
Self-citationZaccardi, F., Ling, S., Lawson, C. A., Davies, M. J., & Khunti, K. (2020) · Diabetologia · doi:10.1007/s00125-020-05223-3 · Cited by 33
Zhu, B., Jin, S., Wu, L., Hu, C., Wang, Z., Bu, L., Sun, H., Wang, X., Qu, S., & Dong, C. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108381 · Cited by 33
Brain Glucose Sensing and the Problem of Relative Hypoglycemia
Schwartz, M. W., Krinsley, J. S., Faber, C. L., Hirsch, I. B., & Brownlee, M. (2023) · Diabetes Care · doi:10.2337/dc22-1445 · Cited by 33
Gregg, E. W., Patorno, E., Karter, A. J., Mehta, R., Huang, E. S., White, M. J., Patel, C. J., McElvaine, A. T., Cefalu, W. T., Selby, J. V., et al. (2023) · Diabetes Care · doi:10.2337/dc22-1438 · Cited by 34
Parsaik, A. K., Carter, R. E., Pattan, V., Myers, L. A., Kumar, H., Smith, S. A., Russi, C. S., Levine, J. A., Basu, A., & Kudva, Y. C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600109 · Cited by 33
Hartl, W. H., Parhofer, K. G., Kuppinger, D., Rittler, P., & Arends, J. (2013) · Aktuelle Ernährungsmedizin · doi:10.1055/s-0033-1349536 · Cited by 33
Zhu, T., Li, K., & Georgiou, P. (2023) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2023.3303367 · Cited by 38
Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
Hanefeld, M., & Bramlage, P. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0366-z · Cited by 33
Complementing Insulin Therapy to Achieve Glycemic Control
Barnett, A. H. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0039-y · Cited by 33
Compliance with treatment and fear of hypoglycaemia in patients with type 2 diabetes
Yuksel, M., & Bektaş, H. (2021) · Journal of Clinical Nursing · doi:10.1111/jocn.15736 · Cited by 34
Boido, A., Ceriani, V., & Pontiroli, A. E. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0665-0 · Cited by 32
Heller, S. R., Buse, J. B., Ratner, R. E., Seaquist, E. R., Bardtrum, L., Hansen, C. T., Tutkunkardas, D., & Moses, A. C. (2019) · Diabetes Care · doi:10.2337/dc18-2361 · Cited by 33
Self-citationThe Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
Choe, E. Y., Cho, Y., Choi, Y., Yun, Y., Wang, H. J., Kwon, O., Lee, B., Ahn, C. W., Soo, B., Lee, H. C., et al. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.3.211 · Cited by 32
The Role of Bromocriptine-Qr in the Management of Type 2 Diabetes Expert Panel Recommendations
Garber, A. J., Blonde, L., Bloomgarden, Z. T., Handelsman, Y., & Dagogo-Jack, S. E. (2013) · Endocrine Practice · doi:10.4158/ep12325.or · Cited by 31
Wei, F., Sun, X., Zhao, Y., Zhang, H., Diao, Y., & Liu, Z. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0300-0 · Cited by 31
Thomas, M. C., Paldánius, P. M., Ayyagari, R., Ong, S. H., & Groop, P. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0189-4 · Cited by 31
Hypoglycaemia and type 1 diabetes are associated with an increased risk of fractures
Jensen, M. H., & Vestergaard, P. (2019) · Osteoporosis International · doi:10.1007/s00198-019-05014-6 · Cited by 31
Brown, J. B., Reichert, S. M., Valliere, Y., Webster-Bogaert, S., Ratzki‐Leewing, A. A., Ryan, B. L., & Harris, S. B. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0074 · Cited by 31
Khunti, K., Hassanein, M. M., Lee, M., Mohan, V., & Amod, A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00833-x · Cited by 32
A Qualitative Study of Perspectives of Older Adults on Deintensifying Diabetes Medications
Pilla, S. J., Meza, K., Schoenborn, N. L., Boyd, C. M., Maruthur, N. M., & Chander, G. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07828-3 · Cited by 34
Hypoglycaemia, chronic kidney disease and death in type 2 diabetes: the Hong Kong diabetes registry
Kong, A. P. S., Yang, X., Luk, A. O. Y., Cheung, K. K., Ronald, C. W., So, W. Y., Ho, C. S., Chan, M. H. M., Ozaki, R., Chow, C. C., et al. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-48 · Cited by 31
Continuous Glucose Monitoring in Small Animals
Surman, S. T., & Fleeman, L. M. (2013) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2013.01.002 · Cited by 31
Hart, H. E., Ditzel, K., Rutten, G. E. H. M., GROOT, E. D., Seidu, S., Khunti, K., & Vos, R. C. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s208947 · Cited by 31
Koto, R., Nakajima, A., Miwa, T., & Sugimoto, K. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01421-5 · Cited by 30
Freemantle, N., Danchin, N., Calvi-Gries, F., Vincent, M., & Home, P. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12598 · Cited by 30
Hypoglycemia as a Driver of Cardiovascular Risk in Diabetes
Moheet, A. A., & Seaquist, E. R. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0351-7 · Cited by 30
Intensive glucose control and hypoglycaemia: a new cardiovascular risk factor?
Rana, O. A., Byrne, C. D., & Greaves, K. (2013) · Heart · doi:10.1136/heartjnl-2013-303871 · Cited by 33
Boyle, P. J., O’Neil, K. W., Berry, C. A., Stowell, S. A., & Miller, S. C. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.11.010 · Cited by 30
Riddle, M. C., Gerstein, H. C., & Cefalu, W. T. (2017) · Diabetes Care · doi:10.2337/dci17-0049 · Cited by 30
Risk of All-Cause Mortality in Diabetic Patients Taking β-Blockers
Tsujimoto, T., Kajio, H., Shapiro, M. F., & Sugiyama, T. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.11.019 · Cited by 30
Wei, W., Zhao, S., Fu, S.-L., Lan, Y., Mao, H., Tan, Q., Xu, P., & Yang, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00536 · Cited by 30
Nishioka, Y., Okada, S., Noda, T., Myojin, T., Kubo, S., Ohtera, S., Kato, G., Kuroda, T., Ishii, H., & Imamura, T. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13153 · Cited by 30
Chiang, C., Ueng, K.-C., Chao, T., Lin, T., Wu, Y.-J., Wang, K.-L., Sung, S., Yeh, H., Li, Y., Liu, P., et al. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000359 · Cited by 30
Yoshinaga, A., Kajihara, N., Kukidome, D., Motoshima, H., Matsumura, T., Nishikawa, T., & Araki, E. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.8008 · Cited by 30
Jin, X., Wang, J., Ma, Y., Li, X., An, P., Wang, J., Mao, W., Mu, Y., Chen, Y., & Chen, K. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.513073 · Cited by 30
Zhang, J., Yang, J., Liu, L., Li, L., Cui, J., Wu, S., & Tang, K. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00753-2 · Cited by 32
Matlock, K. A., Broadley, M. M., Hendrieckx, C., Clowes, M., Sutton, A., Heller, S. R., de Galan, B. E., Pouwer, F., & Speight, J. (2021) · Diabetic Medicine · doi:10.1111/dme.14706 · Cited by 30
Self-citationLevy-Loboda, T., Sheetrit, E., Liberty, I. F., Haim, A., & Nissim, N. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104129 · Cited by 30
Harris, S. B., Khunti, K. K., Landin‐Olsson, M., Galbo-Jørgensen, Bøgelund, Chubb, Gundgaard, & Evans, M. (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s46805 · Cited by 30
Dipeptidyl Peptidase-4 Inhibitor
Murohara, T. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.050 · Cited by 30
Atherosclerotic disease in octogenarians: A challenge for science and clinical practice
de Freitas, W. M., de Carvalho, L. S. F., Moura, F. A., & Sposito, A. C. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.06.070 · Cited by 29
Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy
Monnier, L., Colette, C., Dejager, S., & Owens, D. R. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9325-8 · Cited by 29
Kato, A., Tatsumi, Y., Yako, H., Sango, K., Himeno, T., Kondo, M., Kato, Y., Kamiya, H., Nakamura, J., & Kato, K. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.11.004 · Cited by 29
Monnier, L., Colette, C., Schlienger, J.-L., Bauduceau, B., & Owens, D. R. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.01.007 · Cited by 29
Hypoglycaemia in older home-dwelling people with diabetes- a scoping review
Hermann, M., Heimro, L. S., Haugstvedt, A., Hernar, I., Sigurðardóttir, Á. K., & Graue, M. (2021) · BMC Geriatrics · doi:10.1186/s12877-020-01961-6 · Cited by 29
Wang, Y., Lu, J., Ni, J., Wang, M., Shen, Y., Lu, W., Zhu, W., Bao, Y., Rodbard, D., Vigersky, R. A., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15068 · Cited by 29
Xu, S., Zhang, X., Tang, L., Zhang, F., & Tong, N. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2017.1255537 · Cited by 30
Mi, S., Su, G., Yang, H., Zhou, Y., Tian, L., Zhang, T., & Tao, H. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0217-1 · Cited by 32
Glucagon prescribing and costs among U.S. Adults with diabetes, 2011–2021
Herges, J. R., Galindo, R. J., Neumiller, J. J., Heien, H. C., Umpierrez, G. E., & McCoy, R. G. (2023) · Diabetes Care · doi:10.2337/dc22-1564 · Cited by 28
Muneer, M. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2020_534 · Cited by 28
Hypoglycemia as an indicator of good diabetes care:
Rodríguez‐Gutiérrez, R., Lipska, K. J., McCoy, R. G., Ospina, N. S., Ting, H. H., Montori, V. M., & Hypoglycemia as a Quality Measure in Diabetes Study Group (2016) · BMJ · doi:10.1136/bmj.i1084 · Cited by 30
Saisho, Y. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1776262 · Cited by 28
Sala, L. L., & Pontiroli, A. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910643 · Cited by 28
Glycemic Control and Cardiovascular Disease: What’s a Doctor to Do?
Kishore, P., Kim, S. H., & Crandall, J. P. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0268-5 · Cited by 30
“Mild dysglycemia” in type 2 diabetes: to be neglected or not?
Monnier, L., Colette, C., Dejager, S., & Owens, D. R. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.004 · Cited by 28
A Consensus Perceived Glycemic Variability Metric
Marling, C. R., Struble, N., Bunescu, R., Shubrook, J. H., & Schwartz, F. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700409 · Cited by 28
Klempfner, R., Leor, J., Tenenbaum, A., Fisman, E. Z., & Goldenberg, I. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-60 · Cited by 28
Optimal Glycaemic Control in Elderly People with Type 2 Diabetes: What Does the Evidence Say?
Mathur, S., Zammitt, N. N., & Frier, B. M. (2014) · Drug Safety · doi:10.1007/s40264-014-0247-7 · Cited by 29
Factors influencing inter‐day glycemic variability in diabetic outpatients receiving insulin therapy
Mori, H., Okada, Y., Kurozumi, A., Narisawa, M., & Tanaka, Y. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12551 · Cited by 28
Nguyen, K. T., Diep, B. T. T., Nguyen, V. D. K., Lam, H. V., Tran, K. Q., & Tran, N. Q. (2019) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-019-00755-w · Cited by 28
Review of the veteran affairs diabetes trial: Lessons learned
Tran, K., & Reaven, P. D. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09558-5 · Cited by 27
Diabetes for Cardiologists: Practical Issues in Diagnosis and Management
Mancini, G. B. J., CHENG, A. Y. Y., Connelly, K. A., FITCHETT, D. H., Goldenberg, R., Goodman, S. G., Leiter, L. A., Lonn, E., Paty, B. W., Poirier, P., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.512 · Cited by 27
Dujić, T., Zhou, K., Donnelly, L. A., Leese, G., Palmer, C. N. A., & Pearson, E. R. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13046 · Cited by 27
An Owner-Independent Investigation of Diabetes Alert Dog Performance
Wilson, C., Morant, S. V., Kane, S. A., Pesterfield, C., Guest, C., & Rooney, N. J. (2019) · Frontiers in Veterinary Science · doi:10.3389/fvets.2019.00091 · Cited by 27
Glycaemic control in people with diabetes following acute myocardial infarction
Esdaile, H., Hill, N. E., Mayet, J., & Oliver, N. S. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110644 · Cited by 28
Gajos, G., Konieczyńska, M., Zalewski, J., & Undas, A. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0207-2 · Cited by 27
The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide
Clemens, K. K., McArthur, E., Dixon, S. N., Fleet, J. L., HRAMIAK, I. M., & Garg, A. X. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.01.001 · Cited by 29
Metadata
- Authors
- Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., Grobbee, D. E., Kengne, A. P., Marre, M., & Heller, S.
- Affiliations
- The University of Sydney (AU)
- University Medical Center Utrecht (NL)
- Hôpital Bichat-Claude-Bernard (FR)
- National Health Service (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1410-1418
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2097995302
- Semantic Scholar
- b73e51368b0f6c3d0c425e6670188db927bc8b09
- Cited by
- 1,471
- References
- 31
- Citations by year
- 2026: 33 · 2025: 49 · 2024: 64 · 2023: 60 · 2022: 66 · 2021: 103 · 2020: 119 · 2019: 99 · 2018: 113 · 2017: 103 · 2016: 107 · 2015: 147 · 2014: 106 · 2013: 98 · 2012: 103
- FWCI
- 71.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- severe hypoglycemia, type 2 diabetes, tight glycemic control, macrovascular events, cardiovascular mortality, all-cause mortality, adverse clinical outcomes, diabetes complications, UKPDS
- MeSH terms
- Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Gliclazide, Humans, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Risk Factors, Vascular Diseases, Proportional Hazards Models, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
